FIRST KEY QUESTIONWhy do some people become addicted in the first place, and others not? Why do some people not even like the psychoactive effects of an addictive drug and therefore never start using it? Why can some people use such a drug in moderation and never go on to heavy use and addiction? This extreme variability among people is typical for every addictive drug, from nicotine and alcohol to cocaine and heroin. Might there be some people whose reward pathway is defective in some way from birth, who can only feel “normal” on an opiate, for example, and who discover this the first time they encounter heroin?

People sometimes argue that becoming addicted is a psychologic, not a biologic problem. But behavior, the business of psychology, is also the business of the brain. Until recently, there had been no way to map the living functioning human brain; but now imaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET) have begun to make that possible. Thus, we are actually learning, by imaging techniques, which brain circuits mediate which behaviors.

All of brain anatomy and chemistry is determined, at the outset, by the blueprints in our DNA. Then, through our life experiences, both anatomy (the brain circuitry) and chemistry (the neurotransmitters and their receptors) become modified. Most behaviors are determined by both genetics and environment, one or the other predominating in a particular case.

A researcher brought together for his studies seven pairs of identical twins, boys and girls about four years old. On one occasion he had them sit for a photograph, giving them no special instructions. We have all seen pairs of identical twins, so as we look at this photograph, we are not surprised to see how much alike each pair looks. But there is something amazing. No instructions were given about how to hold their hands, yet as we look more closely we see that every twin pair holds their hands in an identical way. Some twins clasp right hand over left, some clasp left over right, some hold the hands in a closed fist, some rest their hands outstretched on their laps, and so on. Each twin pair displays identical behavior in this simple matter of hand position.

Another researcher brought together adult identical twins who had been reared apart, so identical behavior could not be due to environmental influences. Again, a photograph, and again we see in each twin pair an identical positioning of hands and legs, identical tilt of the head, identical facial expression. No such similarity is seen in fraternal (nonidentical) twins. With respect to these behaviors, then, genetics seems to count for everything.

Those who still doubt that genetics strongly influences behavior should consider working dogs, which are specifically bred for certain behaviors, such as retrieving, pointing, attacking, or herding. In our family there is an Australian Shepherd dog who has never seen a sheep in his life, who was separated from his mother before she could teach him the trade. Yet this animal herds our family with great determination whenever we go for a walk with our children and grandchildren; no one is allowed to stray away from the group.

Animal studies tell us that strains of mice and rats can be bred for willingness or unwillingness to self-administer heroin, for ease or resistance to becoming addicted. In the case of alcohol, we know that there are indeed people who are predisposed (vulnerable) to becoming addicts. That knowledge comes from family, twin, cross-adoption, and pharmacologic studies. And the search is under way for the genes that contribute to the predisposition.

More research is needed to find out if genetic predisposition plays a role in heroin addiction. This is an important issue because if it is true that becoming an addict is not entirely a free choice, but rather is driven by a disorder of brain chemistry, it would validate the disease concept of heroin addiction. And that, in turn, would go far toward removing stigma and legitimizing long-term treatment with an opiate like methadone or LAAM in the eyes of the policy makers, the public, and the addicts themselves.

 

Source:
Neurobiology of Heroin Addiction and of Methadone Treatment
By: Avram Goldstein, M.D.
Professor Emeritus of Pharmacology, Stanford University

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • #aatod2024 ➡️ www.aatodconference.com
  • “Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi

💻 Conference video message #aatod2024 International Chair ➡️ bit.ly/3wjz5sf
  • ✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
  • Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
  • AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
  • View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
  • 💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
  • 💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
  • 3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
  • Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
#aatod2024 ➡️ www.aatodconference.com
#aatod2024 ➡️ www.aatodconference.com
2 hours ago
View on Instagram |
1/10
“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi

💻 Conference video message #aatod2024 International Chair ➡️ bit.ly/3wjz5sf
“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi 💻 Conference video message #aatod2024 International Chair ➡️ bit.ly/3wjz5sf
12 hours ago
View on Instagram |
2/10
✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
✅ Final Reminder 🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024 💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45 📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
23 hours ago
View on Instagram |
3/10
Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
Standard Registration Deadline: TOMORROW - Tuesday, April 30, 2024 Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 Register ➡️ aatodconference.com
2 days ago
View on Instagram |
4/10
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️  TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations. We certainly hope that this is helpful and please let us know if you have any questions.
2 weeks ago
View on Instagram |
5/10
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication https://youtu.be/i6u3qUS95jU
3 weeks ago
View on Instagram |
6/10
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW. #ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
3 weeks ago
View on Instagram |
7/10
💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
💻 Webinar Recording is Now Available AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative. We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. ➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
4 weeks ago
View on Instagram |
8/10
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone. Register ➡️ bit.ly/3Vz1RPE
1 month ago
View on Instagram |
9/10
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  REGISTER ➡ https://conta.cc/3TF9CSQ View the final rule ➡ https://lnkd.in/e_iu-AtG. There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW (Director - CSAT’s Division of Pharmacologic Therapies). The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
1 month ago
View on Instagram |
10/10

AVAILABLE 🗒️ TECHNICAL REVIEW OF @SAMHSA’S FINAL REGS ➡️ http://bit.ly/3w71hOM
This brief can be used by treatment providers/state officials as a quick reference in better understanding the salient policy issues in the new regs. We hope that this is helpful.

Load More...

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD